Introduction
The AP-1 family represents a paradigm for signalresponsive transcription factors. Many of the properties and regulatory functions of eukaryotic transcriptional regulators were initially discovered and described in studies on these proteins (Angel and Karin, 1991; Curran and Franza, 1988) . Similarly, several currently unresolved questions in the ®eld of signal transduction and gene regulation are addressed using the comparatively well-understood AP-1 family as an example. Such questions include: how are dierent extracellular signals integrated by complex networks of cellular information¯ow, and how are dierent incoming signals interpreted by the cell in a manner that takes the context into account, so that sensible and biologically appropriate responses are initiated. The role of c-Jun/AP-1 in stress response and the control of cell growth and apoptosis represents a good example for such complexities. Here we review some recent ®ndings that illustrate the multi-facetted functions of cJun in the control of these cellular responses. For a more comprehensive review on the role of AP-1 factors in MAPK signal transduction see (Ip and Davis, 1998; Karin, 1995; Whitmarsh and Davis, 1996) .
The AP-1 family consists of several groups of bZIPdomain (bZIP=basic region leucine zipper) proteins: the Jun, the Fos, and the ATF-2 subfamilies (Angel and Karin, 1991) . Mammalian Jun proteins include cJun, JunB, and JunD; Fos proteins are c-Fos, FosB, Fra-1 and Fra-2; and the ATF proteins that are customarily included in the AP-1 family are ATF-2 and ATF-a. Like all bZIP transcription factors, AP-1 proteins have to dimerize before they can bind to their DNA target sites identi®ed by the sequences TGACTCA, TGACGTCA, or variants thereof. Dozens of dierent homo-and heterodimeric combinations with dierent regulatory properties, as determined by the characteristics of the subunits, can form. The activity of individual AP-1 components can be regulated at dierent levels. One level is transcriptional. Some AP-1-encoding genes are tightly regulated: c-jun and c-fos are the best-characterized examples of this group. Their expression is subject to regulation by a large number of stimuli and signaling pathways (Whitmarsh and Davis, 1996) . Other AP-1 codinggenes, such as junD and ATF-2, are expressed at fairly constant levels (de Groot et al., 1991; Gupta et al., 1995; Hirai et al., 1989; Van Dam et al., 1995) .
In addition to the intracellular concentrations of these proteins, the speci®c activity of AP-1 factors is subject to regulation at the protein level, by posttranslational modi®cations and interactions with other proteins. The mitogen-activated protein kinase (MAPK) signaling pathways play a predominant role in this regard (Ip and Davis, 1998; Karin et al., 1997; Whitmarsh and Davis, 1996) . These pathways are characterized by modules composed of three protein kinases: MAPKKKs phosphorylate and thereby activate MAPKKs, which in turn phosphorylate MAPKs. The three best-characterized subfamilies of MAPKs are named ERK, JNK and p38. In general, dierent MAPKs are members of separate modules and are regulated by distinct extracellular stimuli. For example, ERKs are activated by receptor tyrosine kinases and relay proliferation or dierentiation signals. JNK and p38-type MAPKs are activated predominantly by stress stimuli and pathogenic insults, but in some cell types also by mitogens. Interestingly, all three classes of MAPKs are involved in the regulation of distinct AP-1 components. c-Jun is regulated by JNK phosphorylation and in some cell types also by ERK-mediated mechanisms. c-Fos is a substrate for regulatory phosphorylations by ERK, and ATF-2 is regulated by JNK and p38 kinases (Karin, 1995; Whitmarsh and Davis, 1996) .
Re¯ecting this baing complexity of regulatory inputs impinging on AP-1 factors, the range of biological responses in which these factors have been implicated is very broad. Signaling by AP-1 transcrip-tion factors has been shown to be involved in, or at least correlated with, phenomena as diverse as cell proliferation, transformation, dierent types of cell dierentiation, cell migration and apoptosis. This review focuses on recent developments in understanding how activation of JNK and c-Jun/AP-1 contributes to dierent cellular responses.
c-Jun and cell proliferation
A role of c-Jun in growth control was ®rst suggested by its ability to transform cells alone or in the presence of a cooperating oncogene (Bos et al., 1990; Castellazzi et al., 1991; Johnson et al., 1996; Lloyd et al., 1991; SchuÈ tte et al., 1989) . In addition, microinjection of antibodies against c-Jun was shown to inhibit progression of cells from G1 into S phase (Kovary and Bravo, 1991) . Studies employing ®broblasts and/or hepatoblasts from c-jun knockout mice demonstrated that c-Jun de®ciency results in a severe proliferation defect, which cannot be compensated by addition of puri®ed mitogens (Eferl et al., 1999; Hilberg et al., 1993; Johnson et al., 1993) . Thus, at least in cultured ®broblasts and hepatoblasts, c-Jun acts as a positive regulator of cell growth.
Even though the molecular mechanisms underlying c-Jun-dependent growth control have not completely been resolved yet, one plausible mechanism by which c-Jun could positively regulate cell cycle progression was described recently and found to involve the tumor suppressor gene p53 . In 3T3 ®broblasts lacking c-Jun, expression of p53 and its target gene, the cyclin-dependent kinase inhibitor p21, is upregulated resulting in impaired cyclin D1 and E-associated kinase activities, and inecient exit of cells from G1 to S phase. It was demonstrated that in ®broblasts, c-Jun acts as a direct negative regulator of p53 expression. Consistently, deletion of p53 in c-jun7/7 cells is sucient to overcome all cell cycle and proliferation defects. In contrast to various stress stimuli, which upregulate p53 levels through a post-translational mechanism, c-Jun rather represses p53 expression at the transcriptional level by directly interacting with the p53 promoter. It is interesting to note that one of the mechanisms reported in the regulation of p53 at the protein level involves JNK, which has been proposed to down-regulate p53 by targeting it for degradation when the JNK signaling pathway is o, i.e. JNK is not catalytically active. Overexpression of c-Jun (Fuchs et al., 1998a) or activation of JNK (Fuchs et al., 1998b) leads to stabilization and accumulation of p53 in mouse ®broblasts. Thus, two components of the JNK pathway, JNK itself and c-Jun, can exert opposing eects on p53. This is puzzling at ®rst, but may be explained by cell type dierences. Furthermore, it is not clear yet whether the putative transcriptional repression of the p53 gene by c-Jun is phosphorylation-dependent, i.e. whether JNK or another MAPK plays a role in this process.
In a separate study, mouse embryo ®broblasts were also found to respond to loss of c-Jun by arresting in G1 phase (Wisdom et al., 1999) . However, in this cellular context, inhibition of cell proliferation is associated with reduced expression of cyclins D1 and D3. Importantly, cyclin D1 promoter activity was shown to be directly controlled by c-Jun. Together, these results establish a molecular link between c-Jundependent mitogenic signaling and cell cycle regulation.
Whether the activity of the JNK pathway and the cJun-mediated proliferation response are connected awaits further clari®cation. Two recent studies using gene targeting suggest that the Jun phosphorylation and/or the JNK pathway is involved. First, ®broblasts, in which endogenous c-jun gene is replaced by a mutant c-jun allele with the MAPK phosphoacceptor serines 63 and 73 changed to nonphosphorylable alanines (Ser63Ala, Ser73Ala), have a proliferation defect in comparison to wild type ®broblasts (Behrens et al., 1999) . Second, sek1-de®cient ®broblasts also grow more slowly than their wild type counterparts (Ganiatsas et al., 1998) . However, in a separate study, which applied recombinant retroviruses directing the expression of dierent c-Jun mutants to rescue the proliferation defect in c-jun7/7 cells, the phoshorylation sites, serines 63 and 73, were found not to be required (Wisdom et al., 1999) . In this context, it is also worth noting that the positive role of JNK pathway and c-Jun in proliferation appears not to be universal but rather a cell-type dependent phenomenon. Unlike in ®broblasts and hepatoblasts, at least in sek7/7 and c-jun7/7 embryonic stem cells, proliferation rates are not aected (Ganiatsas et al., 1998; Hilberg and Wagner, 1992) . Therefore, the net eect of JNK and c-Jun activation depends on the cell context and, presumably, the signaling pathways that are simultaneously activated.
In addition to cell proliferation, c-Jun/AP-1 has been shown to play a role in dierentiation. Studies in cell culture have indicated that c-Jun expression can promote dierentiation of many dierent cell lineages, such as myeloid, neuronal and epithelial cells (LeppaÈ et al., 1998; Lord et al., 1993; Szabo et al., 1994) . In vivo, c-Jun expression is required for viability (Table 1) . Mice lacking c-Jun survive only to embryonic day 12 and die due to massive hemorrhage in the liver. A detailed histological analysis of c-jun7/7 mice revealed that hepatoblasts and erythroid cells in the liver undergo prominent apoptosis (Eferl et al., 1999) . In addition, it was found that c-jun de®ciency results in defects in the heart out¯ow track formation, a malformation resembling congenital human heart defect of a persistent truncus arteriosius (Eferl et al., 1999) . With respect to abnormal hepatogenesis, the sek17/7 phenotype is similar to c-jun de®cient embryos (Ganiatsas et al., 1998; Nishina et al., 1999) . In contrast, mutant mice lacking either JNK1, or JNK2, or JNK3 develop without obvious structural abnormalities. However, JNK1 as well as JNK2 mutant mice exhibit decreased activation-induced Tcell death and imbalance between T H 1 and T H 2 mediated immune responses (Dong et al., 1998; Sabapathy et al., 1999; Yang et al., 1997b Yang et al., , 1998 . In Drosophila, evidence has been presented for an involvement of Jun in several developmental processes. It has been shown that Drosophila Jun can induce photoreceptor dierentiation after being phosphorylated by Drosophila ERK (Bohmann et al., 1994; Peverali et al., 1996) and that it acts as an eector of JNK signaling in the regulation of morphogenetic cellCellular responses to c-Jun and JNK signaling S Leppa È and D Bohmann shape changes (Kockel et al., 1997; Riesgo-Escovar and Hafen, 1997 ).
Jun as a mediator of apoptosis
Although, at ®rst glance, cell proliferation and apoptosis appear to be opposing and mutually contradictory processes, the regulatory systems that control cell growth and cell death are remarkably overlapping. Indeed, a number of proteins that were originally identi®ed as oncogene products and positive growth regulators were subsequently found to play important roles in apoptosis. Examples include Myc and Ras. In the case of c-Jun, ample evidence also exists that links the transcription factor to the control of cell death. However, the function of c-Jun in apoptosis control is rather multi-facetted, and represents a prime example for individual signaling components eliciting dierent or even opposing signal responses in dierent cellular settings.
Perhaps the most illustrative data for c-Jun acting as an inducer of apoptosis have been obtained in studies on neuronally dierentiated cells. Initial studies using PC12 cells and sympathetic neurons showed that inhibition of c-Jun activity, either by microinjection of antibodies against c-Jun or expression of dominant negative mutant forms of the protein protects the cells from nerve growth factor (NGF) withdrawal-induced apoptosis (Estus et al., 1994; Ham et al., 1995; Xia et al., 1995) . Furthermore, ectopic expression of c-Jun is sucient to drive sympathetic neurons into apoptosis in the absence of external stimuli (Ham et al., 1995) . Similarly, overexpression c-Jun was shown to induce apoptosis in 3T3 ®broblasts (Bossy-Wetzel et al., 1997) .
Later studies revealed that, in addition to enhanced cJun expression, phosphorylation of c-Jun by JNK is necessary for the apoptotic response in certain neuronal cell types, including cerebellar granule and sympathetic neurons (Le-Niculescu et al., 1999; Watson et al., 1998) . The most conclusive evidence for the importance of JNK activation and c-Jun phosphorylation for neuronal apoptosis in the animal has been obtained in gene targeting experiments (Table 1) . It was shown that deletion of brain-speci®c jnk3 gene, but not jnk1 or jnk2, causes protection of hippocampal neurons from kainate-induced apoptosis (Dong et al., 1998; Yang et al., 1997b Yang et al., , 1998 . Simultaneously, AP-1-dependent reporter activity, but not the activation of the c-fos and c-jun genes by kainate, is greatly reduced in the jnk3 mutant background, suggesting that the post-translational regulation of AP-1 activity by JNK3 is critical for the triggering of death. In a pleasingly complimentary set of experiments, Wagner and collaborators showed that mice harboring a mutation in the c-jun locus that removes a subset of JNK phosphorylation sites (Ser63Ala, Ser73Ala) are also protected from kainate-induced apoptosis in the hippocampus (Behrens et al., 1999) . The mechanism by which JNK3 and c-Jun promote apoptosis remains obscure. A candidate eector is Fas ligand, which is induced in response to NGF withdrawal and JNK activation in PC12 cells (Le-Niculescu et al., 1999) . Other mediators of JNK signaling during apoptosis could be p53 and the apoptotic protein Bax (Aloyz et al., 1998) .
It has to be stressed that the essential positive role of c-Jun documented in hippocampal neurons exposed to kainate stress is not a re¯ection of a universal role of cJun in cell death or even in neuronal cell death. Mice (Behrens et al., 1999; Erfel et al., 1999; Hilberg et al., 1993; Johnson et al., 1993; Schreiber et al., 1999; Wisdom et al., 1999) c-JunAA Viable As above As above (Behrens et al., 1999) (Ganiatsas et al 1998; Nishina et al., 1996a Nishina et al., ,b, 1998 Nishina et al., , 1999 Yang et al., 1997a) Cellular responses to c-Jun and JNK signaling S Leppa È and D Bohmann lacking the c-Jun phosphorylation sites Ser 63 and 73 show no defects in several forms of normal developmentally regulated apoptosis (Behrens et al., 1999) . Even in the complete absence of c-Fos and c-Jun in double knockout mouse embryos, no defects in the normally occurring developmentally programmed cell death were recorded (Roer-Tarlov et al., 1996) . Consistently, mutant mice de®cient in either the jnk1, jnk2, or jnk3 genes are viable and develop normally (Dong et al., 1998; Yang et al., 1997b; . However, in a recent study, in which dual JNK knockouts were generated, it was found that the dual de®ciency of JNK1 and JNK2 causes embryonic lethality due to severe dysregulation of apoptosis during brain development (Kuan et al., 1999) . Interestingly, depending on the brain region, the response is either pro-apoptotic or anti-apoptotic. This implies that JNK1 and JNK2 regulate the regional speci®city of developmentally regulated apoptosis during brain morphogenesis. In jnk1/jnk2 double knockout embryos, c-Jun is normally expressed and phosphorylated, presumably by JNK3, which further excludes c-Jun as a mediator of normal developmentally regulated apoptosis (Kuan et al., 1999) . Also in Drosophila genetic evidence for a role of JNK signaling in apoptosis in the context of an intact organism has been provided. It was shown that in the developing wing imbalanced BMP-signaling could cause JNK-mediated apoptosis (Adachi-Yamada et al., 1999) . It is not clear yet whether Drosophila Jun or Fos plays a role in this process.
c-Jun in death protection
In contrast to the ®ndings discussed above, which support a role of JNK-Jun signaling in stimulating apoptosis, a growing amount of evidence implicates cJun in the protection of cells from stress-induced apoptosis. The most compelling evidence for c-Jun acting as an anti-apoptotic factor rather than an eector of apoptosis has again been obtained using cJun-de®cient cells. In comparison to wild type cells, cjun7/7 ®broblasts have a greatly reduced capacity to escape apoptosis triggered by UV-induced cell stress. The anti-apoptotic function of c-Jun is phosphorylation dependent, since cells expressing the Ser63Ala, Ser73Ala mutant of c-Jun are not protected from apoptosis triggered by UV irradiation (Wisdom et al., 1999) . Consistent with the cell culture studies, the lack of c-Jun results in massive apoptosis of hepatoblasts and erythroblasts in developing mouse liver in vivo (Eferl et al., 1999) .
Concluding remarks
The AP-1 system has the capacity to funnel a great deal of complex information to a relatively simple promoter element comprised of only 7 or 8 base pairs. The dilemma that the cell faces is how to interpret the activation of AP-1 correctly and ensure that the initiated response, for example apoptosis or survival, is appropriate with regard to the extracellular information received. Several mechanisms have been documented or suggested that could mediate the speci®c interpretation of JNK-Jun signaling by the cell. At the level of gene expression, the question is how AP-1 targets are selected in a cell type or context-dependent manner. Furthermore, one might ask whether there are quantitative, kinetic or qualitative changes in the way in which the transcription of relevant genes is regulated by AP-1 upon stimulation by dierent factors. This might lead the cell to a dierent fate, such as death or survival. All these parameters may be in¯uenced by subtle alterations of the signaling properties within a cell. The eect on target gene activation or repression may be determined by the composition of AP-1 subunits in the cell, by other transcription factors that act in concert with AP-1 on target gene regulatory sequences, or by global eects on chromatin. The latter may be aected by the history of the cell or by extracellular signals (Thomson et al., 1999) . It should also be kept in mind that Jun and Fos proteins have several modes of action. In addition to their`classical role' as TGACTCA-binding AP-1 transcription factors, they can in¯uence gene activity by inhibitory interactions with other transcription factors, such as nuclear receptors or HLH proteins, at the protein level. The presence or absence, or the activation state of such interaction partners in a target cell might alter the quality of the AP-1 response. Finally, it is even conceivable that part of the complexity of the cellular response to AP-1 regulation may not depend on gene regulation at all. Preston et al. (1996) suggested that the Fos-induced apoptosis in Syrian hamster embryo cells is independent of protein synthesis.
Taken together, there are many variables that can in¯uence the cell's receptiveness to and interpretation of JNK and AP-1 activation. Some of these variables are probably the activation state of known proteins, signaling pathways or chromatin domains. Others might be obscure and experimentally harder to grasp (to date!) and include cell-or signal-speci®c dierences in signaling kinetics or topology. It will be a very important task to pull all these building blocks together in order to obtain a comprehensive picture of the mechanisms mediating context-speci®c signal interpretation by the cell.
